OSE Immunotherapeutics schedules KOL webcast on lusvertikimab Sept 2, 2026
OSE Immunotherapeutics will host a KOL webcast dedicated to lusvertikimab on September 2, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.